Philippa Crompton

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study

Xu-Shan Sun, Yungan Tao, Christophe Le Tourneau et al. · The Lancet Oncology · 2020 · 130 citations

Medicine, Oncology, Radiation Oncology +11

Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double‐blind, placebo‐controlled study

Naveed Sattar, Philippa Crompton, Lynne Cherry et al. · Arthritis & Rheumatism · 2007 · 119 citations

Medicine, Pharmacology, Pharmacotherapy +16

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

Yungan Tao, Xu-Shan Sun, Y. Pointreau et al. · European Journal of Cancer · 2023 · 54 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Christophe Le Tourneau, Yungan Tao, Carlos Gomez‐Roca et al. · Clinical Cancer Research · 2020 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1

Caroline Robert, Célèste Lebbé, Thierry Lesimple et al. · Clinical Cancer Research · 2022 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17